Increased carbonic anhydrase IX is associated with non-small cell lung cancer

HIF-1alpha and CA IX, but not VEGF or MMP-9, may have a role in progression of surgically resected non-small cell lung cancer

High carbonic anhydrase IX expression is associated with non-small cell lung cancers

MN/CA9 gene expression was detected in 53/59 (89.8%) pleural effusions from cancer patients (15/16 breast cancers, 10/11 lung cancers, 4/4 ovary cancers, 2/3 colon-rectal cancers, 5/6 cancers of unknown site, 7/8 mesothelioma & 10/11 other cancers)

CSF1, EGFR, and CA IX have roles in increasing survival in early-stage squamous cell carcinoma of the lung

independent prognostic factor in non-small cell lung cancer; high levels of mRNA are predictive of unfavorable outcome

High membranous CA IX is associated with non-small cell lung cancer.

High expression of CAIX in tumour tissue is a predictor of worse survival, and a high CAIX plasma level is an independent prognostic biomarker in patients with non small cell lung cancer, in particular in early-stage I+II carcinomas.

carbonic anhydrase XII has a role in good prognosis in resectable non-small cell lung cancers

The high expression of CAIX in non-small cell lung cancer tissues is correlated with VEGF level but not with Ki67 level.

A critical role for re-oxygenation on CAIX and CAXII levels that may select for an aggressive lung cancer phenotype.

CAIX serum level was significantly higher in patients with lung cancer than that in the healthy group.

Results provide evidence that CAIX induces chemoresistance of A549 cells, a lung cancer cell line.

Our results do not suggest a prognostic role for CA IX overexpression in stage III non-small cell lung cancer patients who received neoadjuvant treatment.

Carbonic anhydrase 9 (CA9) expression in non-small-cell lung cancer: correlation with regulatory FOXP3+T-cell tumour stroma infiltration.